tm
Seeing Is Believing
tm
Seeing Is Believing
BOLT is currently covered by 2 analysts with an average price target of $6.5. This is a potential upside of $63.04 (99.39%) from yesterday's end of day stock price of $3.26.
Bolt Biotherapeutics's activity chart (see below) currently has 3 price targets and 11 ratings on display. The stock rating distribution of BOLT is 25% HOLD and 75% BUY.
Analysts average stock forecasts to be materialized ratio is 12.96% with an average time for these price targets to be met of 29.56 days.
Highest price target for BOLT is $7, Lowest price target is $6, average price target is $6.5.
Most recent stock forecast was given by from HC WAINWRIGHT on 28-May-2026. First documented stock forecast 02-Mar-2021.
Currently out of the existing stock ratings of BOLT, 1 are a HOLD (25%), 3 are a BUY (75%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 20-Oct-2025
$7
$2.72 (63.55%)
$7
Hold Since 03-Sep-2025
$6
$1.72 (40.19%)
Buy Since 15-Aug-2025
$75
$70.62 (1612.33%)
Hold Since 15-May-2024
$30
$25.24 (530.25%)
What is BOLT (Bolt Biotherapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on BOLT (Bolt Biotherapeutics) with a proven track record?
Which analyst has the most public recommendations on BOLT (Bolt Biotherapeutics)?
Which analyst is the currently most bullish on BOLT (Bolt Biotherapeutics)?
Which analyst is the currently most reserved on BOLT (Bolt Biotherapeutics)?
